We are live on ! Find out more
MP

Manikay Partners Portfolio holdings

AUM $893M
1-Year Est. Return 55.39%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
+55.39%
3 Year Est. Return
+91.67%
5 Year Est. Return
+189.23%
10 Year Est. Return
AUM
$1.62B
AUM Growth
-$358M
Cap. Flow
-$348M
Cap. Flow %
-21.47%
Top 10 Hldgs %
55.23%
Holding
41
New
9
Increased
10
Reduced
6
Closed
10

Sector Composition

Rank Sector Weight
1 Financials 22.7%
2 Consumer Discretionary 12.56%
3 Consumer Staples 11.89%
4 Healthcare 9.18%
5 Technology 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
C icon
26
PUT
Citigroup
C
$222B
$25.8M 1.59%
500,000
-500,000
-50% -$25.5M
XLS
27
DELISTED
EXELIS INC COM STK
XLS
$19.5M 1.2%
+799,996
New +$17.1M
KCG
28
DELISTED
KCG Holdings, Inc.
KCG
$15.9M 0.98%
1,300,000
+1,061,575
+445% +$13.1M
HAWK
29
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
$13.2M 0.82%
372,500
+31,986
+9% +$1.14M
VALE.P
30
DELISTED
Vale S A
VALE.P
$11.5M 0.71%
2,370,000
-287,500
-11% -$1.82M
LO
31
DELISTED
LORILLARD INC COM STK
LO
$3.15M 0.19%
+48,151
New +$3.21M
STZ icon
32
Constellation Brands
STZ
$22.3B
-850,000
Closed -$83.4M
RVBD
33
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
-2,000,000
Closed -$40.8M
GFIG
34
DELISTED
GFI GROUP INC
GFIG
-1,000,000
Closed -$5.45M
CFN
35
DELISTED
CAREFUSION CORPORATION
CFN
-552,762
Closed -$32.8M
SWY
36
DELISTED
SAFEWAY INC
SWY
-2,600,600
Closed -$91.3M
AUXL
37
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
-1,900,000
Closed -$65.3M
CBST
38
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
-875,000
Closed -$88.1M
GRT
39
DELISTED
GLIMCHER REALTY TRUST
GRT
-3,500,000
Closed -$48.1M
COV
40
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
-850,000
Closed -$86.9M
AGN
41
DELISTED
Allergan Inc
AGN
-650,000
Closed -$138M

Similar funds

Manikay Partners's Q1 2015 Portfolio in Review

As of Q1 2015, Manikay Partners held 41 positions worth $1.62B, down 18% from $1.98B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Manikay Partners withdrew a net $348M in Q1 2015, closing 10 positions and reducing 6 holdings. Its most notable exit was Allergan Inc, an estimated $138M position sold in full.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Manikay Partners opened a new position in Allergan plc worth $76.3M.

  • Manikay Partners's largest Q1 2015 buy was Allergan plc: 256,527 shares worth $76.3M.
  • Manikay Partners added most to Citizens Financial Group in Q1 2015, an estimated $43.6M increase.
  • Manikay Partners's biggest Q1 2015 reduction was HUDSON CITY BANCORP INC, cutting an estimated $39M.
  • Manikay Partners fully exited Allergan Inc in Q1 2015, selling an estimated $138M.
  • Manikay Partners's ten largest holdings make up 55% of its $1.62B portfolio in Q1 2015.
  • Manikay Partners opened 9 new positions and closed 10 in Q1 2015.
  • Manikay Partners's portfolio value fell 18% quarter-over-quarter to $1.62B.

Based on Manikay Partners's 13F filing for Q1 2015, filed 14 May 2015.